SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

20201,334 citationsReviewbronze Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 396, Issue 10254, pp. 819-829

Field-Weighted Citation Impact: 125.87